Kelley Shannon T
SEC CIK 2034056 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | GC | 11.5K | — | $1.54M | 9 | 2024-08-15 | 2026-08-17 |
Most active insiders at MDGL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FRIEDMAN PAUL A | Dir | — | $26.66M |
| 2 | Taub Rebecca | Dir | — | $21.68M |
| 3 | Sibold William John | Pres, CEO, Dir | — | $10.48M |
| 4 | BATE KENNETH | Dir | — | $8.03M |
| 5 | Levy Richard S | Dir | — | $7.36M |
| 6 | Dier Mardi | EVP, CFO | — | $3.77M |
| 7 | Huntsman Carole | Chief Commercial Off | — | $1.71M |
| 8 | Soergel David | Chief Medical Off | — | $952.0K |
| 9 | Kelley Shannon T | GC | — | $841.6K |
| 10 | Thakkar Rita | CAO | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 16:20 | 2026-08-17 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Kelley Shannon T | GC | S - Sale | $514.97 | -664 | 11.5K | -5% | -$341.9K | |
| D | 2026-03-06 | 2026-03-06 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Kelley Shannon T | GC | S - Sale | $431.94 | -360 | 12.1K | -3% | -$155.5K |
| D | 2026-03-06 | 2026-03-04 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Kelley Shannon T | GC | A - Grant | $0.00 | +4,017 | 12.5K | +47% | $0 |
| M | 2026-01-20 | 2026-01-20 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Kelley Shannon T | GC | S - Sale | $497.36 | -692 | 8,910 | -7% | -$344.2K |
| M | 2025-08-18 | 2025-08-18 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Kelley Shannon T | GC | S - Sale | $367.81 | -1,304 | 9,215 | -12% | -$479.6K |
| D | 2025-03-07 | 2025-03-05 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Kelley Shannon T | GC | A - Grant | $0.00 | +3,187 | 10.5K | +44% | $0 |
| 2025-03-05 | 2025-03-03 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Kelley Shannon T | GC | S - Sale | $335.00 | -415 | 7,290 | -5% | -$139.0K | |
| 2025-01-17 | 2025-01-17 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Kelley Shannon T | GC | S - Sale | $273.41 | -277 | 7,705 | -3% | -$75.7K | |
| D | 2024-08-19 | 2024-08-15 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Kelley Shannon T | GC | A - Grant | $0.00 | +5,215 | 7,982 | +188% | $0 |
Purchase Sale Sale after option exercise All abbreviations